Event description

Attendees will learn how to map their technology and scale-up needs to key funding programs, including currently-open Horizon Europe and LIFE Programme calls relevant to sustainable proteins, circular bioeconomy, and bio-based chemicals—highlighting award sizes (€2M–10M), cost-share requirements, and how to join consortia as a startup or U.S.-based entity. The session will also provide practical advice on what makes a competitive grant application. Specifically, in this webinar, you’ll learn how to identify and apply for public investment from U.S. state and federal agencies and EU entities.

Topics will include:

  • Identifying and determining eligibility for government grants, loans, and tax incentive opportunities
  • Application best practices
  • Strategic priorities for U.S. and EU public investment and how alternative protein companies can best position their technologies
  • Audience Q&A

Meet the speaker

Joel armin-hoiland

Joel Armin-Hoiland

FOUNDER AND CEO OF CLIMATE FINANCE SOLUTIONS

Joel Armin-Hoiland is the Founder and CEO of Climate Finance Solutions (CFS), a global consultancy that helps climate tech companies secure large-scale grant funding and other public financing. CFS has secured over $1.6 billion in grant funding since 2020 and has won over 90% of the dollars it has applied for. Its global team also has experience securing over €400 million in EU climate funding. While it exclusively supports climate solutions, CFS is sector agnostic and works with the full range of industry verticals, as well as across all technology and company stages, from early and applied R&D through large-scale demonstration and deployment. CFS provides services throughout the grants lifecycle, from identification and assessment to funding strategy, funder engagement, proposal development, and post-award management.

Upcoming events

View all events
An illustration of the globe with two hands reaching towards one another.  third party event featured image.
Virtual Event

New Proteins webinar

Join GFI’s Abby Sewell for a look at how hybrid and diversified protein strategies are shaping the future of food.

An illustration of the globe with two hands reaching towards one another.  third party event featured image.
Tuskegee University

Future of Food: Engaging Agriculture and Education in the Protein Transition

GFI’s Jeremy Eltz and Janie Butler are heading to Tuskegee to lead a dynamic workshop at the Professional Agricultural Workers Conference.

Https://gfi. Org/wp content/uploads/2025/11/sci25060 boap webinar graphics november header featured
Virtual Event

The Business of Alt Protein: Green Financing for Alternative Proteins—Introducing the Climate Bonds Alternative Proteins Criteria

Join GFI’s next Business of Alt Protein webinar featuring a deep dive on the Climate Bonds Initiative’s new Alternative Proteins Criteria.

An illustration of the globe with two hands reaching towards one another.  third party event featured image.
Javits Center

Plant Based World Expo

Join GFI’s Corporate Engagement Manager Abby Sewell at Plant Based World Expo, the only professional 100% plant-based trade event in the U.S.

An illustrative graphic of a microscope on a stack of books

The 7th Industrializing Cultivated Meat & Seafood Summit

GFI’s Elliot Swartz, Ph.D., will share insights at the 7th Industrializing Cultivated Meat & Seafood Summit in Boston. Join Elliot and other experts as they discuss R&D innovations that can…

Https://gfi. Org/wp content/uploads/2025/09/sci25055 ap pipeline webinar graphics october header featured
Virtual Event

Alt Protein Pipelines: Training for commercialization with production facility partnerships

Join us to explore an innovative partnership that is helping students turn classroom learning into commercial-ready innovation.

Https://gfi. Org/wp content/uploads/2025/11/sci25061 soap webinar graphics dec header featured
Virtual Event

The Science of Alt Protein: Glycoengineering fungal cell factories — Implications for recombinant protein production

Join us to learn how using advanced gene-editing tools to reprogram fungi opens new possibilities for recombinant protein production.